FDA Adverse Event Injury Summary report: N

INFUSE BONE GRAFT

MDR report key: 3163397 · Received June 11, 2013

Report

Report Number
1030489-2013-02214
Event Type
Injury
Date Received
June 11, 2013
Report Date
September 12, 2016
Manufacturer
MEDTRONIC SOFAMOR DANEK USA, INC
Product Code
NEK
PMA / PMN Number
P000058
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
MN, US
Reporter Occupation
ATTORNEY

Narratives

Additional Manufacturer Narrative · 1

(B)(4): NEITHER THE DEVICE NOR FILMS OF APPLICABLE IMAGING STUDIES WERE RETURNED TO THE MANUFACTURER FOR EVALUATION. THEREFORE, WE ARE UNABLE TO DETERMINE THE DEFINITIVE CAUSE OF THE REPORTED EVENT.

Additional Manufacturer Narrative · 1

A GOOD FAITH EFFORT WILL BE MADE TO OBTAIN THE APPLICABLE INFORMATION RELEVANT TO THE REPORT. IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED.

Additional Manufacturer Narrative · 1

IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED.

Description of Event or Problem · 1

IT WAS REPORTED BY A NON-MEDICAL PROFESSIONAL THAT THE PATIENT UNDERWENT A PROCEDURE FOR ANTERIOR L5-S1 FUSION WHERE RHBMP-2 WAS IMPLANTED INSIDE AND OUTSIDE THE INTERBODY CAGES. SUBSEQUENTLY, THE PATIENT WAS ALLEGEDLY DIAGNOSED WITH ECTOPIC BONE GROWTH, AN INFLAMMATORY REACTION TO RHBMP-2/ACS, CHRONIC PAIN, AND ADDITIONAL SURGERIES.

Description of Event or Problem · 1

IT WAS REPORTED THAT ON (B)(6) 2003 , PATIENT PRESENTED WITH FOLLOWING PRE-OP DIAGNOSES: HISTORY OF ATTEMPTED L4-L5 FUSION. L4-L5 PSEUDOARTHROSIS WITH INTRACTABLE POSTSURGICAL MECHANICAL LOW BACK PAIN AND INSTABILITY. DEGENERATIVE DISK DISEASE. THE PATIENT UNDERWENT FOLLOWING PROCEDURES: ANTERIOR EXPOSURE OF LUMBAR SPINE WITH EXPLORATION OF L4-5 FUSION AND REACTION OF PSEUDOARTHROSIS. INTRAOPERATIVE FLUOROSCOPY. SUPERVISION AND INTERPRETATION OF X-RAYS. L4-5 ANTERIOR LUMBAR INTERBODY FUSION WITH APPLICATION OF INTERVERTEBRAL FUSION CAGES WITH BONE MORPHOGENIC PROTEIN. PER OP NOTES, "...16X23 MM LT CAGES WERE OBTAINED. BONE MORPHOGENIC PROTEIN HAD BEEN RECONSTITUTED IN THE USUAL MANNER IN ANTICIPATION OF FUSION AND WAS NOW PLACED WITHIN CAGES. THE LT CAGES WERE THEN ADVANCED INTO THE L4-L5 INTERSPACE UNDER FLUOROSCOPIC GUIDANCE. PATIENT TOLERATED THE PROCEDURE WELL WITHOUT ANY INTRAOPERATIVE COMPLICATIONS..."

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
264180 INFUSE BONE GRAFT FILLER, RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN, COLLAGEN SCAFFOLD WITH MET NEK MEDTRONIC SOFAMOR DANEK USA, INC NA MC111001D

Patients

Seq Age Sex Outcome Treatment
1 00055 YR Required Intervention